Dynamic Capital Management’s Myriad Genetics MYGN Stock Holding History

Dynamic Capital Management’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-7,349	Closed	-$275K	–	410
2015 Q3	$275K	Buy	+7,349	New	+$261K	0.08%	307
2014 Q2	–	Sell	-14,564	Closed	-$498K	–	454
2014 Q1	$498K	Sell	14,564 -167,555	-92%	-$5.19M	0.16%	209
2013 Q4	$3.82M	Buy	182,119 +108,053	+146%	+$2.73M	0.72%	21
2013 Q3	$1.74M	Sell	74,066 -40,234	-35%	-$1.14M	0.39%	61
2013 Q2	$3.07M	Buy	+114,300	New	+$3.31M	0.81%	24

Other funds holding MYGN

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Dynamic Capital Management's MYGN Position: Q4 2015 in Review

Dynamic Capital Management sold out of Myriad Genetics (MYGN) in Q4 2015, closing a stake of 7,349 shares — an estimated $275K sold.

Dynamic Capital Management first reported a position in MYGN in Q2 2013 and held it in 5 quarters. The position peaked at $3.82M in Q4 2013. 232 funds tracked by Wall St. Rank hold MYGN as of Q4 2015.

Dynamic Capital Management reported no remaining Myriad Genetics position as of Q4 2015 after selling out during the quarter.
Dynamic Capital Management sold 7,349 Myriad Genetics shares in Q4 2015, an estimated $275K.
Dynamic Capital Management first reported a position in Myriad Genetics in Q2 2013 and held it in 5 quarters.
Dynamic Capital Management's Myriad Genetics position peaked at $3.82M in Q4 2013.
232 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2015.

Based on Dynamic Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.